This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

October 25-28, 2021
Delivered in a 100% Digital Format in EST Time Zone

Scott Umlauf
Head of Bioassay Biosafety and Impurities, Biopharmaceuticals Development, R & D at AstraZeneca


Scott is currently serving as the head of Bioassays, Biosafety and Impurities clinical method development at AstraZeneca in Gaithersburg, MD. Previously, Scott has worked in cell-based assay development with a focus on immunology and molecular biology at several companies in biotech and pharma, including Bristol Myers-Squibb, VaxInnate and PowderJect Vaccines. Prior to his industry work, Scott received his PhD in Cellular and Molecular Biology from the University of Wisconsin-Madison, and did a post-doctoral fellowship in the Laboratory of Cellular and Molecular Immunology at the NIH.

Agenda Sessions

  • KEYNOTE: Development of Potency Assays for Multi-target Biologics: Challenges and Opportunities